Epidemiology and natural history of NAFLD and NASH
- PMID: 17544968
- DOI: 10.1016/j.cld.2007.02.009
Epidemiology and natural history of NAFLD and NASH
Abstract
Understanding of the epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD) has increased; it is the most common form of chronic liver disease in the Western world and increasing in importance in other parts of the world. Prevalence is expected to increase as obesity and diabetes epidemics evolve. The natural history of NAFLD depends on the histologic subtype. Those who have simple hepatic steatosis or nonspecific inflammation generally have a benign long-term prognosis, whereas non-alcoholic steatohepatitis (NASH) can progress to cirrhosis. NASH-related cirrhosis may have a similar prognosis as cirrhosis from other causes, leading to liver failure or hepatocellular carcinoma.
Similar articles
-
Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.Diabetes Metab. 2008 Dec;34(6 Pt 2):634-7. doi: 10.1016/S1262-3636(08)74597-X. Diabetes Metab. 2008. PMID: 19195623
-
Nonalcoholic fatty liver disease.Minerva Med. 2008 Dec;99(6):583-93. Minerva Med. 2008. PMID: 19034256 Review.
-
Non-alcoholic steatohepatitis in children.Pediatr Transplant. 2004 Dec;8(6):613-8. doi: 10.1111/j.1399-3046.2004.00241.x. Pediatr Transplant. 2004. PMID: 15598336 Review.
-
[Non-alcoholic fatty liver].Rev Gastroenterol Peru. 2003 Jan-Mar;23(1):49-57. Rev Gastroenterol Peru. 2003. PMID: 12768215 Review. Spanish.
-
Non-alcoholic fatty liver disease and hepatitis C infection.Minerva Gastroenterol Dietol. 2006 Jun;52(2):135-43. Minerva Gastroenterol Dietol. 2006. PMID: 16557185 Review.
Cited by
-
Targeting the Liver-Brain Axis with Hop-Derived Flavonoids Improves Lipid Metabolism and Cognitive Performance in Mice.Mol Nutr Food Res. 2020 Aug;64(15):e2000341. doi: 10.1002/mnfr.202000341. Epub 2020 Jul 6. Mol Nutr Food Res. 2020. PMID: 32627931 Free PMC article.
-
Fatty liver: a link to cardiovascular disease--its natural history, pathogenesis, and treatment.Methodist Debakey Cardiovasc J. 2012 Jul-Sep;8(3):21-5. doi: 10.14797/mdcj-8-3-21. Methodist Debakey Cardiovasc J. 2012. PMID: 23227282 Free PMC article. Review.
-
Interobserver Agreement on Pathologic Features of Liver Biopsy Tissue in Patients with Nonalcoholic Fatty Liver Disease.J Pathol Transl Med. 2016 May;50(3):190-6. doi: 10.4132/jptm.2016.03.01. Epub 2016 Apr 18. J Pathol Transl Med. 2016. PMID: 27086596 Free PMC article.
-
TM6SF2-rs58542926 Genetic Variant Modifies the Protective Effect of a "Prudent" Dietary Pattern on Serum Triglyceride Levels.Nutrients. 2023 Feb 23;15(5):1112. doi: 10.3390/nu15051112. Nutrients. 2023. PMID: 36904112 Free PMC article.
-
Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non-alcoholic fatty liver disease.Aliment Pharmacol Ther. 2019 Jan;49(1):64-73. doi: 10.1111/apt.15030. Epub 2018 Nov 14. Aliment Pharmacol Ther. 2019. PMID: 30430605 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical